More Press Releases

View Older Stories View Newer Stories

May 21, 2026 05:13PM Buzz Capital Inc. Announces Non-Brokered Private Placement
May 21, 2026 05:13PM Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations
May 21, 2026 05:09PM Fidelity Investments Canada Closes the Market
May 21, 2026 05:10PM Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026
May 21, 2026 12:38PM 80% of Individual Contributors Say Their Manager’s Approach to AI is Hands-Off, FranklinCovey Research Finds
May 21, 2026 05:08PM Defesio LLC CEO Believes That Health Care Organizations And Clinics Not Using Quantum Resistant Email May Not Be Technically HIPAA Compliant Anymore.
May 21, 2026 05:07PM Logitech Files Annual Report on Form 10-K
May 21, 2026 05:05PM Cleantek Industries Inc. First Quarter 2026 Interim Update
May 21, 2026 05:07PM Equus Announces First Quarter Net Asset Value
May 21, 2026 05:06PM Whale Dynamic Joins Hitch Open World AI Championships as Official Mapping Technology Partner, Delivering Centimeter-Accurate HD Map of Tianmen Mountain for 2026 Racing Season
May 21, 2026 05:05PM Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload
May 21, 2026 05:05PM Remix Therapeutics Announces Positive Data from Phase 1/2 ARIA Study of First-in-Class MYB mRNA Degrader, REM-422, in Patients with Adenoid Cystic Carcinoma (ACC) at the American Society of Clinical O
May 21, 2026 05:05PM Aulos Bioscience Reports Positive Phase 2 Data for Imneskibart in Doublet Checkpoint Inhibitor-Refractory Metastatic Melanoma at 2026 ASCO Annual Meeting
May 21, 2026 05:05PM Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology
May 21, 2026 05:05PM Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology
May 21, 2026 05:05PM North American Construction Group Ltd. Announces Voting Results of Annual and Special Meeting of Shareholders
May 14, 2026 10:10AM /C O R R E C T I O N -- VidantaWorld/
May 21, 2026 05:03PM Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting
May 21, 2026 05:02PM Imperial Announces Voting Results for the Election of Directors
May 21, 2026 05:00PM DATA Communications Management Corp. Report of Voting Results Annual and Special Meeting of Shareholders Held on May 21, 2026
May 21, 2026 05:00PM Saturn Oil & Gas Inc. Announces Approval of All Resolutions and Voting Results of Annual and Special Shareholder Meeting
May 21, 2026 05:02PM Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin
May 21, 2026 05:01PM Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis
May 21, 2026 05:01PM Agendia to Present New FLEX Study Data at ASCO 2026 Supporting NCCN Clinical Practice Guidelines in Oncology Update Recognizing MammaPrint for Guiding Anthracycline Use in Early-Stage Breast Cancer
May 21, 2026 05:01PM Bristol Myers Squibb to Unveil New Data at ASCO® 2026 Demonstrating Strength and Breadth of Scientific Innovation Across Oncology Portfolio and Next-Generation Pipeline
May 21, 2026 05:01PM Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated Pancreatic Cancer Models
May 21, 2026 05:01PM Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data
May 21, 2026 05:00PM Medicure Announces AGM Results and Appointment of New Director
May 21, 2026 05:00PM Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
May 21, 2026 05:00PM IC Group Announces Q1 2026 Earnings Release Date and Investor Webinar
May 21, 2026 05:00PM AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit
May 21, 2026 05:00PM Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026
May 21, 2026 05:00PM TruGolf Reports First Quarter 2026 Results
May 21, 2026 05:00PM HiberCell to Present Preliminary Results from the Phase 1b Trial of GCN2 Activator HC-7366 when Combined with WELIREG® (belzutifan) for the Treatment of Late-Line Clear Cell Renal Cell Carcinoma (ccR
May 21, 2026 05:00PM Canadian Net REIT Announces 2026 First-Quarter Results and a Distribution Increase
May 21, 2026 05:00PM Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline
May 21, 2026 05:00PM Zodiac Partners II, LLC Provides an Update to its Previously Announced $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash
May 21, 2026 05:00PM NVIDIA Announces Upcoming Events for Financial Community
May 21, 2026 05:00PM Accent Therapeutics to Present Trial in Progress Poster for Phase 1/2 Study of ATX-295 at the 2026 American Society of Clinical Oncology Annual Meeting
May 21, 2026 05:00PM Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC
May 21, 2026 05:00PM Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
May 21, 2026 05:00PM Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting
May 21, 2026 05:00PM Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy
May 21, 2026 05:00PM WhiteFiber Signs AI Compute Agreement with Total Contract Value in Excess of $160 Million with Investment-Grade Technology Customer
May 21, 2026 05:00PM Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC
May 21, 2026 05:00PM Greenberg Traurig Bolsters Government Contracts and Space Practices with Shaun Kennedy in Denver
May 21, 2026 05:00PM Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026
May 21, 2026 05:00PM New Clinical Data for Izalontamab Brengitecan and Novel ADC Pipeline to be Presented at ASCO 2026
May 21, 2026 05:00PM Navient declares second quarter common stock dividend
May 21, 2026 05:00PM Dell Technologies to Present at Investor Conference in June
View Newer Stories View Older Stories